ASPI vs ATI vs Q Stock Comparison

ASP Isotopes, Ati and Qnity Electronics Prices as of Oct 23, 2026 Peers: Industry group
ASPI ASP Isotopes Inc.
$1.95 -35.2% 1M -79.6% 1Y
Market cap
$248.50M
P/E
–
Revenue (TTM)
$30.85M
Div. yield
–
Specialty Chemicals Basic Materials
1 win
ATI Ati Inc
$156.88 -14.7% 1M +75.2% 1Y
Market cap
$22.42B
P/E
47.1x
Revenue (TTM)
$4.72B
Div. yield
–
Specialty Chemicals Basic Materials
4 wins
Q Qnity Electronics, Inc.
$109.85 -11.8% 1M
Market cap
$23.93B
P/E
40.8x
Revenue (TTM)
$5.21B
Div. yield
0.00%
Specialty Chemicals Basic Materials
5 wins

Head to Head

10 decided of 12

Qnity Electronics leads on 5 of the 12 questions below (Qnity Electronics 5, Ati 4, ASP Isotopes 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionASPIATIQLeader
Larger companyMarket capitalisation $248.50M $22.42B $23.93B Q
Cheaper on earningsLower P/E, profitable companies only -2.1x 47.1x 40.8x Q
Cheaper on forward earningsLower price / next fiscal year consensus EPS — 32.9x 25.3x Q
Faster revenue growthRevenue growth, trailing twelve months +573.4% +4.6% +14.8% ASPI
More profitableNet margin, trailing twelve months -380.3% 10.1% 11.2% Q
Better return on capitalReturn on invested capital -28.6% 14.9% 8.3% ATI
Less leveragedLower net debt / EBITDA 2.1x 1.6x 1.8x ATI
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months -79.6% +75.2% — ATI
Better 5-year returnAnnualised price return, 5 years — +58.0%/yr — –
Less volatileAnnualised volatility, 1 year 98.8% 41.7% 55.2% ATI
Higher overall scoreMean of the five percentile scores vs peers 26/100 58/100 61/100 Q

Percentile Scorecard

ASPIATIQ

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisASPIATIQ
Valuation 9 #86 of 94 14 #81 of 94 39 #58 of 94
Growth 19 #75 of 92 88 #12 of 92 52 #45 of 92
Profitability 8 #82 of 89 91 #9 of 89 88 #12 of 89
Financial Health 69 #31 of 97 49 #50 of 97 68 #32 of 97
Shareholder Returns – 48 #37 of 70 58 #30 of 70
Overall 26 58 61
  • ASPI ranked among 99 companies in Chemicals
  • ATI ranked among 99 companies in Chemicals
  • Q ranked among 99 companies in Chemicals

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodASPIATIQSPY
1 month -35.2%-14.7%-11.8% -1.0%
3 months -49.6%-20.7%-18.7% +2.9%
6 months -63.6%+1.7%-24.0% +6.4%
Year to date -63.6%+36.7%+34.5% +11.4%
1 year -79.6%+75.2%— +13.1%
3 years +77.3%+329.0%— +79.4%
3 years, per year +21.0%+62.5%— +21.5%
5 years —+882.3%— +67.7%
5 years, per year —+58.0%— +10.9%
10 years —+782.8%— +255.2%
10 years, per year —+24.3%— +13.5%

Risk

MeasureASPIATIQSPY
Volatility, 1Y 98.8%41.7%55.2% 12.7%
Downside volatility, 1Y 99.5%40.3%58.5% 12.7%
Beta vs S&P 500, 1Y 3.881.632.64 1.00
Return / volatility, 1Y -0.811.80— 1.03
Max drawdown, 5Y -88.6%-38.0%-38.1% -25.4%
From 52-week high -81.9%-32.3%-37.5% -2.5%
52-week high $10.76$231.79$175.64 $779.14
52-week low $1.95$89.25$73.54 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleASPIATIQ
P/E now vs peer median -2.0xmedian 21.5x 44.9xmedian 21.5x 39.3xmedian 21.5x
P/S now vs peer median 8.2xmedian 1.4x 4.5xmedian 1.4x 4.4xmedian 1.4x
EV/EBITDA now vs peer median -0.6xmedian 12.4x 25.5xmedian 12.4x 15.1xmedian 12.4x
P/FCF now vs peer median -3.0xmedian 15.5x 40.6xmedian 15.5x 27.9xmedian 15.5x
P/B now vs peer median 0.9xmedian 1.6x 10.7xmedian 1.6x 3.0xmedian 1.6x
PEG now vs peer median 0.05median 1.70 5.07median 1.70 —median 1.70

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsASPIATIQ
Revenue $30.85M $4.72B $5.21B
Gross profit $5.65M $1.10B $2.41B
Operating income -$99.07M $716.80M $1.34B
Net income -$117.34M $488.90M $630.00M
Free cash flow -$83.58M $526.30M $825.00M
R&D $22.04M – $374.00M
EPS (diluted) $-0.96 $3.44 $2.79
Cash & equivalents $219.60M $783.00M $961.00M
Total debt $59.77M $2.19B $9.77B
Shares (diluted) 122.72M 138.30M 210.20M
Enterprise value -$738.21M $20.44B $21.07B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricASPIATIQ
P/E -2.0x 44.9x 39.3x
P/FCF -3.0x 40.6x 27.9x
P/Operating cash flow -3.7x 26.5x 19.7x
P/S 8.2x 4.5x 4.4x
P/B 0.9x 10.7x 3.0x
P/Tangible book 0.9x 10.7x 3.5x
EV/EBITDA -0.6x 25.5x 15.1x
EV/EBIT -0.6x 31.8x 19.5x
EV/Revenue 1.9x 4.8x 5.0x
EV/FCF -0.7x 43.3x 31.6x
EV/Operating cash flow -0.9x 28.3x 22.3x
PEG (3Y EPS CAGR) 0.05 5.07 –

Growth

14 metrics
MetricASPIATIQ
Revenue growth (1Y) 573.4% 4.6% 14.8%
Revenue CAGR (3Y) 2,420% 4.5% –
Gross profit growth (1Y) 214.3% 15.7% 13.3%
Gross profit CAGR (3Y) – 12.6% –
Operating income growth (1Y) -200.2% 8.8% 11.6%
Operating income CAGR (3Y) -105.1% 16.4% –
Net income growth (1Y) -17.1% 12.9% -23.6%
Net income CAGR (3Y) -119.1% 5.8% –
EPS growth (1Y) 30.3% 17.9% -26.4%
EPS CAGR (3Y) -37.1% 8.9% –
Operating cash flow growth (1Y) -244.7% 69.9% –
Operating cash flow CAGR (3Y) -151.6% – –
Free cash flow growth (1Y) -182.5% 123.6% –
Free cash flow CAGR (3Y) -123.3% – –

Profitability

14 metrics
MetricASPIATIQ
Gross margin 18.3% 23.4% 46.2%
EBITDA margin -303.3% 18.9% 33.0%
Operating margin -321.1% 15.2% 25.6%
Pretax margin -443.4% 12.7% 16.9%
Net margin -380.3% 10.1% 11.2%
FCF margin -270.9% 11.2% 15.8%
Operating cash flow margin -219.8% 17.1% 22.4%
Return on equity -40.9% 25.2% 8.4%
Return on assets -20.2% 8.9% 4.4%
Return on invested capital -28.6% 14.9% 8.3%
Return on capital employed -19.4% 17.6% 10.5%
Asset turnover 0.1x 0.9x 0.4x
Cash conversion (OCF / net income) 0.6x 1.6x 1.9x
Stock comp / revenue 60.5% 0.6% 0.7%

Financial Health

11 metrics
MetricASPIATIQ
Debt / assets 10.4% 38.2% 28.1%
Debt / equity 0.2x 1.1x 0.5x
Net debt / EBITDA 2.1x 1.6x 1.8x
Debt / FCF -0.7x 4.2x 4.9x
Liabilities / assets 52.0% 65.2% 47.3%
Equity / assets 48.0% 34.8% 52.7%
Interest coverage -25.3x – 7.1x
Current ratio 3.9x 2.3x 2.0x
Quick ratio 3.7x 1.1x 1.5x
Cash ratio 3.6x 0.6x 0.7x
Altman Z-score -0.25 5.23 2.85

Shareholder Returns

7 metrics
MetricASPIATIQ
Dividend yield – – 0.3%
Net buyback yield – 1.3% 0.2%
Shareholder yield – 1.3% 0.5%
Payout ratio (earnings) – – 5.4%
Payout ratio (FCF) – – 4.1%
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusASPIATIQ
Forward P/E – 32.9xFY2026 25.3xFY2026
EPS, next fiscal year $-0.45FY2026 $4.77FY2026 $4.34FY2026
EPS growth, next FY – +47.2%FY2026 +29.6%FY2026
EPS growth, the year after – +23.5% +21.7%
Revenue, next fiscal year $24.34MFY2026 $5.24BFY2026 $5.34BFY2026
Revenue growth, next FY +2.0%FY2026 +14.2%FY2026 +12.5%FY2026
Revenue growth, the year after +189.0% +13.1% +23.3%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersASPIATIQ
Held by institutions 50.3% 93.5% –
Institutions holding 186 785 –
Change in shares held, QoQ +3.3% +0.9% –
Institutions buying 113 478 –
Institutions selling 53 217 –
Buyers to sellers 2.13 2.20 –

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ASPIATIQ
ASPI 1.00 0.37 0.38
ATI 0.37 1.00 0.50
Q 0.38 0.50 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ASPI, ATI and Q?

Qnity Electronics (Q) is the largest by market capitalisation: ASP Isotopes (ASPI) $248.50M, Ati (ATI) $22.42B, Qnity Electronics (Q) $23.93B.

Which stock is cheaper, ASPI, ATI and Q?

Qnity Electronics (Q) trades on the lowest price-to-earnings ratio (ASP Isotopes (ASPI) -2.1x, Ati (ATI) 47.1x, Qnity Electronics (Q) 40.8x). On next year's consensus earnings, Qnity Electronics (Q) is cheapest (Ati (ATI) 32.9x, Qnity Electronics (Q) 25.3x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

ASP Isotopes (ASPI) grew revenue fastest over the trailing twelve months: ASP Isotopes (ASPI) +573.4%, Ati (ATI) +4.6%, Qnity Electronics (Q) +14.8%.

Which company is more profitable?

Qnity Electronics (Q) has the highest net margin (ASP Isotopes (ASPI) -380.3%, Ati (ATI) 10.1%, Qnity Electronics (Q) 11.2%). On return on invested capital, Ati (ATI) leads (ASP Isotopes (ASPI) -28.6%, Ati (ATI) 14.9%, Qnity Electronics (Q) 8.3%).

Which stock has performed better?

Over the past year Ati (ATI) returned the most: ASP Isotopes (ASPI) -79.6%, Ati (ATI) +75.2%. Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: ASP Isotopes (ASPI) 0.00%, Ati (ATI) 0.00%, Qnity Electronics (Q) 0.00%. ASP Isotopes (ASPI) and Ati (ATI) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Ati (ATI) has been the steadiest (ASP Isotopes (ASPI) 98.8%, Ati (ATI) 41.7%, Qnity Electronics (Q) 55.2%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ASPI, ATI and Q?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Qnity Electronics (Q) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.